Incyte Aktie

Kaufen

Verkaufen

Incyte Aktien-Sparplan Incyte Aktien-Sparplan

71,50 EUR -0,08 EUR -0,11 %

24.09.2025

BMN

84,14 USD -0,40 USD -0,47 %

24.09.2025

BTT

Incyte jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.14,06 Mrd. EUR

KGV445,90Div. Rendite0,00%

WKN896133

ISINUS45337C1027

SymbolINCY

Incyte Aktien News

Sortieren:Datum Meistgelesen

03.02.25ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?

20.01.25ZacksIncyte Gains 15.3% in a Year: Is There Room for Further Growth?

15.01.25PR NewswireIncyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes

15.01.25ZacksZacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines

14.01.25BenzingaIncyte At JPM25: Eyes Transformational 2025 With Multiple Drug Launches And Expanding Pipeline

13.01.25ZacksHas Incyte (INCY) Outpaced Other Medical Stocks This Year?

19.12.24BenzingaThe Analyst Verdict: Incyte In The Eyes Of 15 Experts

28.11.24ZacksWhy Is Incyte (INCY) Up 2.1% Since Last Earnings Report?

19.11.24ZacksIncyte Pauses Enrollment in Chronic Spontaneous Urticaria Study

19.11.24BenzingaWhat's Going On With Incyte Shares Tuesday?

19.11.24BenzingaAecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

14.11.24BenzingaCracking The Code: Understanding Analyst Reviews For Incyte

29.10.24BenzingaIncyte Clocks Mixed Q3 Earnings, But Analyst Sees A Strong Quarter For Jakafi And Opzelura

29.10.24BenzingaCorning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday

29.10.24ZacksHere's What Key Metrics Tell Us About Incyte (INCY) Q3 Earnings

29.10.24ZacksIncyte (INCY) Q3 Earnings Miss Estimates

23.10.24BenzingaPeeling Back The Layers: Exploring Incyte Through Analyst Insights

22.10.24ZacksIncyte Gears Up to Report Q3 Earnings: Here's What You Should Know

10.10.24BenzingaA Look Into Incyte Inc's Price Over Earnings

01.10.24BenzingaAssessing Incyte: Insights From 11 Financial Analysts

25.09.24ZacksIncyte Gains 12.7% Year to Date: How Should You Play the Stock?

24.07.23PR NewswireSyndax and Incyte Announce Positive Topline Results from the Pivotal AGAVE-201 Trial of Axatilimab in Chronic Graft-Versus-Host Disease

19.04.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY

07.03.23PR NewswireCaris Life Sciences and Incyte Enter Into Broad Precision Medicine Partnership to Advance Incyte's Oncology Pipeline

05.12.22PR NewswireSyndax Pharmaceuticals and Incyte Announce Axatilimab Phase 1/2 Data in Patients with Chronic Graft-Versus-Host Disease Published in the Journal of Clinical Oncology

01.11.22RSSForm 8-K 879169

05.10.22RSSInitial statement of beneficial ownership of securities

03.04.20ReutersNovartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19

03.04.20ReutersRPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19

03.04.20ReutersNovartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19

Incyte News

Incyte News: auf dieser Seite finden Sie alle Incyte News und Nachrichten zur Incyte Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Incyte News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Incyte News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.